It was reported to gore that a gore-tex® vascular graft was implanted on (b)(6) 2018, in a (b)(6) male patient to treat an acute ischemia located at the right lower limb.On (b)(6) 2018, after about 8 days, the gore-tex® vascular graft was explanted due to a thrombosis leading to a transfemoral amputation.
|
Additional information was entered for the following: result code 213: a review of the manufacturing records confirmed that the lot met all pre-release specifications.Result code 213: refer to explant evaluation summary.The gore-tex® vascular graft was returned to geprovas, independent laboratory, for investigation.The scope and results of the investigation were summarized and a report was submitted to w.L.Gore & associates.An explant investigator (ei) at w.L.Gore & associates reviewed the report.The following is a summary of the ei observations: minimal, scattered plaques of dark red/brown material on the albumen surface.Lumens were fully obstructed with dark red/brown and white/tan thrombotic material.Both poles were transected.Extremity a was ovular in shape.No defect on the eptfe membrane was observed during the macroscopic analysis.From gross images all material disruptions (i.E., material transections), appear to be consistent with cutting by sharp surgical instruments (i.E., scalpel or scissors), likely used during the explant procedure.Further analysis is not needed as the material disruptions are consistent with those caused by surgical instrumentation during the explant process.
|